Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Lymphoma × glofitamab × Clear all

Phase

Status

Recruiting 3 Not yet recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Large B-Cell, Diffuse 4 Lymphoma, Mantle-Cell 2 Dendritic Cell Sarcoma, Interdigitating 2 Recurrence 1 Lymphoma 1 Ann Arbor Stage II Mantle Cell Lymphoma 1

Interventions

obinutuzumab 2 Rituximab 2 Immunotherapy, Adoptive 2 Bendamustine Hydrochloride 2 zanubrutinib 1 selinexor 1 sargramostim 1 orelabrutinib 1 glofitamab 1 Sulfasalazine 1 Sirolimus 1 Prednisone 1 Lenalidomide 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06867536 2025-03-18

GLOHRT-01

Huazhong University of Science and Technology

Phase 2 Not yet recruiting

Lymphoma, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡